Neurologic complications after intrathecal liposomal cytarabine in combination with systemic polychemotherapy in primary CNS lymphoma (Q85209756)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20953896%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

title

Neurologic complications after intrathecal liposomal cytarabine in combination with systemic polychemotherapy in primary CNS lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20953896%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

Kathrin Ostermann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20953896%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Hendrik Pels

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20953896%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Annika Kowoll

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20953896%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Jan Kuhnhenn

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20953896%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Uwe Schlegel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20953896%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

publication date

17 October 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20953896%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuro-Oncology

15 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20953896%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20953896%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20953896%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

635-640

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20953896%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11060-010-0435-y

15 February 2020

exact match

0 references

cites work

Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II study

1 reference

12 December 2020

Extended CSF cytarabine exposure following intrathecal administration of DTC 101.

1 reference

12 December 2020

Safety and toxicity of intrathecal liposomal cytarabine (Depocyte) in children and adolescents with recurrent or refractory brain tumors: a multi-institutional retrospective study

1 reference

12 December 2020

A pharmacokinetic study of intra-CSF administered encapsulated cytarabine (DepoCyt) for the treatment of neoplastic meningitis in patients with leukemia, lymphoma, or solid tumors as part of a phase III study

1 reference

12 December 2020

Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma

1 reference

12 December 2020

Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma

1 reference

12 December 2020

Intrathecal liposomal cytarabine for prevention of meningeal disease in patients with acute lymphocytic leukemia and high-grade lymphoma.

1 reference

12 December 2020

Efficacy and safety of liposomal cytarabine in lymphoma patients with central nervous system involvement from lymphoma

1 reference

12 December 2020

Primary Central Nervous System Lymphoma: Results of a Pilot and Phase II Study of Systemic and Intraventricular Chemotherapy With Deferred Radiotherapy

1 reference

12 December 2020

Treatment of lymphomatous and leukemic meningitis with liposomal encapsulated cytarabine.

1 reference

12 December 2020

An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis

1 reference

12 December 2020

Pharmacokinetics of intralumbar DTC-101 for the treatment of leptomeningeal metastases

1 reference

12 December 2020

Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis.

1 reference

12 December 2020

Intrathecal liposomal cytarabine in children under 4 years with malignant brain tumors.

1 reference

12 December 2020

Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia

1 reference

12 December 2020

Neurological complications after intrathecal liposomal cytarabine application in patients after allogeneic haematopoietic stem cell transplantation.

1 reference

12 December 2020

1 reference

12 December 2020

Radiotherapy in the treatment of primary central nervous system lymphoma (PCNSL).

1 reference

12 December 2020

Therapeutic challenges in primary CNS lymphoma

1 reference

12 December 2020

Liposomal cytarabine (DepoCyte) for the treatment of neoplastic meningitis

1 reference

12 December 2020